Determination of Baseline Levels for Prostate Cancer-Derived Extracellular Vesicles Following Local Treatment of Prostate Cancer

A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer

NCT05169684 ·Status: TERMINATED ·Phase: PHASE2

Search for Predictive Factors of Resistance to Treatment for Metastatic Castration-resistant Prostate Cancer by Studying the Expression of microRNAs

NCT04662996 ·Status: COMPLETED ·Phase: NA

Molecular Studies and Clinical Correlations in Human Prostatic Disease

NCT00578240 ·Status: ACTIVE_NOT_RECRUITING

A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer

NCT01322490 ·Status: COMPLETED ·Phase: PHASE3

Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC

NCT04506567 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

M6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

NCT03517969 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY

NCT02269982 ·Status: COMPLETED

Exercise in Prostate Cancer

NCT06165302 ·Status: RECRUITING ·Phase: NA

Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence

NCT02070575 ·Status: COMPLETED

Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

NCT06200103 ·Status: RECRUITING ·Phase: PHASE2

Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer

NCT07073794 ·Status: RECRUITING ·Phase: PHASE2

A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or Death

NCT03619980 ·Status: COMPLETED

SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00006002 ·Status: COMPLETED ·Phase: PHASE2

Exisulind Versus Placebo After Surgical Removal of the Prostate

NCT00166426 ·Status: COMPLETED ·Phase: PHASE2

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

NCT02066961 ·Status: COMPLETED

PROCARE - PROstate Cancer Real World Evidence Registry

NCT06835218 ·Status: RECRUITING

Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients

NCT02376296 ·Status: COMPLETED

A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer

NCT06533644 ·Status: RECRUITING ·Phase: PHASE2

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

NCT04729114 ·Status: RECRUITING ·Phase: PHASE1

Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer

NCT01560923 ·Status: COMPLETED ·Phase: PHASE2

XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT06568562 ·Status: RECRUITING ·Phase: PHASE2

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

NCT03678025 ·Status: RECRUITING ·Phase: PHASE3

Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer

NCT06014255 ·Status: RECRUITING ·Phase: PHASE2

Exercise for Advanced Prostate Cancer: a Multicomponent Feasibility Trial

NCT03658486 ·Status: COMPLETED ·Phase: NA

Phase 1 of EC1169 In Patients With Recurrent MCRPC

NCT02202447 ·Status: COMPLETED ·Phase: PHASE1